Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Z Analyzer who wrote (2056)	5/5/1998 11:57:00 AM
From: B.REVERE	Read Replies (1) \| Respond to of 9523

[THANKS]-- I wish more posters like you could preach the stock down. I couldn't get more at 114, but was able to buy another 100 at 110 1/4. Thanks again,

To: Z Analyzer who wrote (2056)	5/5/1998 3:49:00 PM
From: Perry	Read Replies (2) \| Respond to of 9523

With all due respect I'll stick with my brokers analysis that clearly points out that valuations for PFE is not excessive based on the P/E premium. However, like I said we'll know in a few months who is right. Good luck. Perry BTW, earnings may be earnings but clearly if Viagra earns more than you estimate, then the so called winfall may be added to R&D which basicaly in the long run will make or break any pharmaceutical company. This is basically what WLA CEO said. i.e. that the lipitor earnings will help them increase the R&D.